Tech giant Google is partnering with Novartis to manufacture contact lenses that will help to manage diabetes in a more efficient manner. This offers potential to transform eye care and enable Novartis to compete in a global blood-sugar tracking market that is expected to be worth more than $12 billion by 2017.
This technology provides a continuous, minimally invasive measurement of the body’s glucose levels via a “smart contact lens” which is designed to measure tear fluid in the eye and connects wirelessly with a mobile device. Non-invasive sensors, microchips and other miniaturized electronics would be embedded into the contact lenses.
The other application is treating presbyopia, in which ageing eyes have trouble focusing on close objects. The smart lens has the potential to help restore the eye’s natural autofocus on near objects in the form of an accommodative contact lens or intraocular lens as part of the refractive cataract treatment.
What do you think of this path breaking product? Will you use this when it comes to the market? Please share your views here.
A recent study in UK, conducted on more than 80,000 people who took an intelligence…
The healthcare sector in India is one of the fastest growing sectors and has exhibited…
Globally, Sept 17 is celebrated as the 'Patient Safety Day' and was established in 2019…
This article was published on June 7, 2020 in the Economic Times ET Health: https://bit.ly/3gZDFzf…
In the continuing combat against the existing pandemic, contact tracing apps are proving to be…
Technology has certainly revolutionised the way health care is provided and received across the globe.…
This website uses cookies.